Moderna Inc. buy Royal Bank of Canada
Start price
28.03.24
/
50%
€98.67
Target price
28.03.25
€115.68
Performance (%)
-70.98%
End price
29.03.25
€28.63
Summary
This prediction ended on 29.03.25 with a price of €28.63. The BUY prediction by Royal_Bank_of_Canada for Moderna Inc. performed very badly with a performance of -70.98%. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Moderna Inc. | 3.339% | 3.339% | 110.828% |
| iShares Core DAX® | 0,41 % | 8,82 % | 12,26 % |
| iShares Nasdaq 100 | 3,68 % | 10,82 % | 44,02 % |
| iShares Nikkei 225® | 2,70 % | 15,25 % | 48,04 % |
| iShares S&P 500 | 2,44 % | 7,93 % | 33,00 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $125.00 price target on the stock.
Ratings data for MRNA provided by MarketBeat
In the thread Trading Moderna Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten